PVD

HP Unlocks New Era of AI Experiences Powering Work and Creation

Retrieved on: 
måndag, maj 20, 2024
Microsoft, HP Inc., Intelligence, Work, Machine learning, Privacy, Create, Life, Physical vapor deposition, Engineering, AI, Personal computer, PVD, ARM, HP OmniBook, Microsoft Excel, NPU, HP, Certification, AI accelerator, Microsoft Teams, Software, TB, Best Buy, CPU, Communication, Creativity, Medical device

REDMOND, Wash., May 20, 2024 (GLOBE NEWSWIRE) -- Today HP Inc. unveiled a new class of next-generation AI PCs at Microsoft’s AI Vision Event designed for the AI era to empower people to work and create more meaningfully.

Key Points: 
  • To capitalize on both flexible work and AI, HP has created a new category of devices crafted for work and creation.
  • Today, HP unveiled the HP OmniBook X AI PC and HP EliteBook Ultra AI PC, HP’s first next-gen AI PCs built from the ground up with the latest ARM architecture to harness the most powerful AI technologies.
  • Both PCs feature HP’s new AI Helix Logo , reflecting HP AI engineering that delivers optimized performance and security for AI today.
  • Explore & Optimize – First available on today’s next-gen AI PCs, HP AI Companion uses AI to optimize the device for greater productivity while bringing AI tools locally onto the device.

Apple Music celebrates the greatest records ever made with the launch of inaugural 100 Best Albums list

Retrieved on: 
måndag, maj 13, 2024
TV and Radio, Technology, Music, Podcast, Digital Marketing, Social Media, Media, Entertainment, Blogging, Online, Mobile Entertainment, Influencer, Apps, Applications, Communications, Software, Audio, Video, Consumer Electronics, Gold, Apple Music, Friends, Code, Table, Prejudice, Apple Podcasts, Name, PVD, Apple Inc., Zane Lowe, Apple Music 1, Record

Fans will also be treated to a full 100 Best Albums Radio takeover on Apple Music Hits, broadcasting round-the-clock specials with Apple Music Radio hosts, daily specials at 9 a.m. PT (noon ET), plus exclusive content dropping every day on demand on Apple Music and Apple Podcasts.

Key Points: 
  • Fans will also be treated to a full 100 Best Albums Radio takeover on Apple Music Hits, broadcasting round-the-clock specials with Apple Music Radio hosts, daily specials at 9 a.m. PT (noon ET), plus exclusive content dropping every day on demand on Apple Music and Apple Podcasts.
  • Apple Music will keep the momentum going after the countdown ends with an additional week of 100 Best Albums Radio takeover on Apple Music Hits.
  • Explore Apple Music’s 100 Best Albums at 100best.music.apple.com and check back daily to discover the full list.
  • Apple, the Apple logo and Apple Music are trademarks of Apple.

Prospective Study Shares Early Clinical Experience with Shape Memory Polymer Vascular Plugs for Pelvic Venous Disease

Retrieved on: 
måndag, maj 13, 2024
General Health, Surgery, Medical Devices, Infectious Diseases, Health, Patient, Doctor of Philosophy, Female, European Journal, CPP, Leal, Vascular surgery, Magnetic resonance, Blood, Pelvic pain, PVD, Gynaecology, Interventional radiology, University of Navarra, Chronic pain, Woman, Pain, Multimedia, Memory, Birth control

Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced the publication of a prospective observational study looking at the use of a single shape memory polymer plug, the IMPEDE-FX Embolization Plug, as the embolization agent to treat female pelvic venous disease (PVD).

Key Points: 
  • Shape Memory Medical Inc., developer of custom shape memory polymers for endovascular markets, announced the publication of a prospective observational study looking at the use of a single shape memory polymer plug, the IMPEDE-FX Embolization Plug, as the embolization agent to treat female pelvic venous disease (PVD).
  • In this prospective, observational case series, Jose Ignacio Leal Lorenzo, MD, PhD, and lead author, reports encouraging outcomes in this early experience.
  • Early Experience on Embolisation of Female Pelvic Venous Disease With a Single Shape Memory Vascular Plug: A Prospective Magnetic Resonance Imaging Based Evaluation, published by Leal et al, is available via open access at https://authors.elsevier.com/a/1iutJ3rFXltnme .
  • For more information about Shape Memory Polymer for Pelvic Venous Disorders, visit www.shapemem.com/pelvic-health .

FOX Factory Performance Vehicle Development Introduces the All-New Black Widow Limited Chevrolet Silverado 1500

Retrieved on: 
torsdag, maj 9, 2024
FOX, Safety, Black, BDS, PVD, Fox Factory, Limited Edition, Life insurance

TRUSSVILLE, Ala., May 09, 2024 (GLOBE NEWSWIRE) -- Black Widow Trucks, a division of FOX Factory Performance Vehicle Development (PVD) group, is eager to unveil the highly anticipated Black Widow Limited Chevrolet® Silverado® 1500.

Key Points: 
  • TRUSSVILLE, Ala., May 09, 2024 (GLOBE NEWSWIRE) -- Black Widow Trucks, a division of FOX Factory Performance Vehicle Development (PVD) group, is eager to unveil the highly anticipated Black Widow Limited Chevrolet® Silverado® 1500.
  • The Black Widow Limited Chevrolet® Silverado® 1500 takes comfort, style, and performance to yet another level, further cementing the already iconic Black Widow name.
  • Making the Black Widow Limited Chevrolet® Silverado® 1500 stand out in any crowd is the all-new Metallic Matte paint scheme.
  • As with our other Black Widow models, these Black Widow Limited Chevrolet® Silverado® 1500s include a 3-year/36,000-mile warranty on every component.

EQS-News: SINGULUS TECHNOLOGIES Develops new Solutions for the Production of Solid-State Batteries

Retrieved on: 
fredag, maj 3, 2024
Hydrogen, Photovoltaics, Safety, Risk, News, PVD, Battery, Spacecraft, Wind, Engineering, Environment, PECVD, Glass, Electric battery

Kahl am Main, April 25, 2024 - SINGULUS TECHNOLOGIES has received a development order for production equipment that will be used for specific production processes of new solid-state batteries and contribute to an efficient manufacturing process.

Key Points: 
  • Kahl am Main, April 25, 2024 - SINGULUS TECHNOLOGIES has received a development order for production equipment that will be used for specific production processes of new solid-state batteries and contribute to an efficient manufacturing process.
  • SINGULUS TECHNOLOGIES uses its expertise in surface technology to industrialize the production of solid-state batteries.
  • Dr. Stefan Rinck, CEO of SINGULUS TECHNOLOGIES, explains: "We are developing and building a production system with innovative process technology that will make a significant contribution to the manufacture of the new solid-state batteries.
  • With its expertise in surface technology, SINGULUS TECHNOLOGIES is well equipped to overcome these challenges and offer innovative solutions for the production of such solid-state batteries.

EQS-News: SINGULUS TECHNOLOGIES - Innovative PVD sputtering systems for the production of bipolar plates for fuel cells and electrolyzes

Retrieved on: 
fredag, maj 3, 2024
Proton, Hydrogen, Climate change, Photovoltaics, Electrode, Physical vapor deposition, News, Singulus Technologies, EUROPE, MEA, PVD, Electricity, Membrane, Research, Transport, Battery, Water, Gold, Proton-exchange membrane, Oxygen, PECVD, PEM, Glass, Electrolysis, Growth

SINGULUS TECHNOLOGIES is already successfully coating bipolar plates on a pilot scale with industrial and research partners.

Key Points: 
  • SINGULUS TECHNOLOGIES is already successfully coating bipolar plates on a pilot scale with industrial and research partners.
  • With its inline coating systems, SINGULUS TECHNOLOGIES offers significant advantages over batch systems and thus enables cost-effective production of bipolar plates suitable for series production as demand increases.
  • An outstanding feature of the PVD systems from Singulus TECHNOLOGIES is the company's extensive process knowledge.
  • The modular GENERIS PVD inline sputtering system from SINGULUS TECHNOLOGIES enables the variable deposition of different layers systems and, with a flexible substrate carrier system, offers the possibility of coating bipolar plates in all common sizes.

EQS-News: SINGULUS TECHNOLOGIES develops TIMARIS STM Coating System for the Production of Micro-LEDs

Retrieved on: 
fredag, maj 3, 2024
Hydrogen, Photovoltaics, Light-emitting diode, News, PVD, Research, Battery, Micrometer, PECVD, MRAM, Glass

Kahl am Main, April 17, 2024 - SINGULUS TECHNOLOGIES has introduced a modular high-vacuum sputtering system of the type TIMARIS STM.

Key Points: 
  • Kahl am Main, April 17, 2024 - SINGULUS TECHNOLOGIES has introduced a modular high-vacuum sputtering system of the type TIMARIS STM.
  • The system offers significant progress in a specialized segment of semiconductor production: the manufacture of micro-LEDs.
  • The first TIMARIS STM system has already been sold and delivered.
  • The introduction of micro-LED technologies has revolutionized the display industry and continues to promise exciting developments in various application areas.

EQS-News: SINGULUS TECHNOLOGIES publishes invitation to vote in a vote without meeting

Retrieved on: 
onsdag, april 10, 2024
Hydrogen, Glass, Bond, WKN, PVD, News, Federal Gazette, Photovoltaics, Battery, PECVD, Security (finance)

SINGULUS TECHNOLOGIES publishes invitation to vote in a vote without meeting (Bond, ISIN: DE000A2AA5H5, WKN: A2AA5H)

Key Points: 
  • SINGULUS TECHNOLOGIES publishes invitation to vote in a vote without meeting (Bond, ISIN: DE000A2AA5H5, WKN: A2AA5H)
    Kahl am Main, April 10, 2024 - SINGULUS TECHNOLOGIES AG (SINGULUS TECHNOLOGIES) publishes an invitation to vote in a vote without meeting pursuant to § 18 and §§ 5 et seq.
  • The complete invitation to vote will be available from April 10, 2024, in the Federal Gazette and on the website of SINGULUS TECHNOLOGIES (www.singulus.com) under the link https://www.singulus.com/de/glaeubigerversammlung/.
  • SINGULUS TECHNOLOGIES proposes to the bondholders to amend the bond terms and conditions by several points and looks forward to welcoming the bondholders to the vote without a meeting.
  • 3 sentence 1 SchVG) has not been reached, SINGULUS TECHNOLOGIES will invite to a subsequent second bondholders' meeting.

CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy

Retrieved on: 
lördag, april 6, 2024
Guillain–Barré syndrome, Bone marrow, Medical College of Wisconsin, Encephalopathy, Survival, Immunotherapy, BCMA, Patient, Hypotension, Mortality, B-cell maturation antigen, Edema, Periodic breathing, Associate professor, Dexamethasone, Certification, Neutropenia, Dizziness, Risk, Headache, Chills, Myelodysplastic syndrome, Coagulopathy, DPD, Johnson & Johnson, Immune system, Effect, Fatigue, Thrombocytopenia, Food, Disease, Drive, Appetite, Lymphocytopenia, JNJ, Constipation, Multiple myeloma, Acute myeloid leukemia, CRS, Death, Hypersensitivity, Cytopenia, Cytokine release syndrome, ASCO, Use, Hematology, FDA, PVD, Annual general meeting, T cell, DSM-IV codes, Incidence, Tachycardia, Bortezomib, Diarrhea, Viral, Hope, United, Cough, Daratumumab, Nausea, Society, Division, Physician, Pharmaceutical industry

HORSHAM, Pa., April 5, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent, and are refractory to lenalidomide.1 With this approval, CARVYKTI® becomes the first and only B-cell maturation antigen (BCMA)-targeted therapy approved for the treatment of patients with multiple myeloma as early as first relapse.

Key Points: 
  • "This milestone underscores our commitment to improve outcomes for patients and transform the treatment of multiple myeloma with CARVYKTI," said Jordan Schecter, M.D., Vice President, Disease Area Leader, Multiple Myeloma, Johnson & Johnson Innovative Medicine.
  • CARVYKTI® is a cell therapy that works by harnessing a patient's immune system, or T cells, to fight the disease.
  • Treatment requires extensive training, preparation, and certification to ensure a positive experience for patients.
  • Since initial approval in February 2022, Johnson & Johnson has made significant advances in manufacturing to rapidly scale CARVYKTI® production.

Rado True Square x Kunihiko Morinaga Special Edition

Retrieved on: 
onsdag, mars 27, 2024
Element, The Swatch Group, Titanium, Partnership, PVD, Special edition, Light, Rado, Heart, Water, Sunlight, Multimedia, Movement, Video game

LENGNAU, Switzerland, March 27, 2024 /PRNewswire/ -- In 2017, Rado collaborated with the visionary Japanese fashion designer Kunihiko Morinaga to create a limited-edition timepiece that blended the brand's renowned mastery of materials with the color-changing technology for which the avant-garde designer is so well known. Rado and Morinaga have announced the release of their latest shared masterpiece, the Rado True Square x Kunihiko Morinaga Special Edition watch.

Key Points: 
  • Rado and Morinaga have announced the release of their latest shared masterpiece, the Rado True Square x Kunihiko Morinaga Special Edition watch.
  • It's no surprise that the new Rado True Square x Kunihiko Special Edition watch is visually breathtaking.
  • The Rado True Square x Kunihiko Morinaga is presented on a polished black high-tech ceramic bracelet secured by a titanium three-fold clasp.
  • The Rado True Square x Kunihiko Morinaga Special Edition is the result of a natural partnership between an innovative brand and a disruptive fashion visionary who are dedicated to blending the boundaries between technology and design.